Inhibition of VEGF induces cellular sene
β
Mohammad R. Hasan; Shirley H. Y. Ho; David A. Owen; Isabella T. Tai
π
Article
π
2011
π
John Wiley and Sons
π
French
β 774 KB
## Abstract Vascular endothelial growth factor (VEGF) inhibitors, such as bevacizumab, have improved outcomes in metastatic colorectal cancer (CRC). Recent studies have suggested that VEGF can delay the onset of cellular senescence in human endothelial cells. As VEGF receptors are known to be upreg